Filing Details

Accession Number:
0001731122-22-001013
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-27 20:30:22
Reporting Period:
2022-05-25
Accepted Time:
2022-05-27 20:30:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314052 Anavex Life Sciences Corp. AVXL Biological Products, (No Disgnostic Substances) (2836) 208365999
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360570 Athanasios Skarpelos 630 5Th Avenue
20Th Floor
New York NY 10111
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-25 50,000 $0.92 1,356,458 No 4 M Direct
Common Stock Disposition 2022-05-25 50,000 $9.06 1,306,458 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2022-05-25 50,000 $0.00 50,000 $0.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-04-02 No 4 M Direct
Footnotes
  1. The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015.